fda compounding semaglutide warning 2025 october issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of New project announcement: HHS‑OIG is

Because we continue to say that we're a leader in better-for-you, we believe in healthier living, but we wanted to make sure that we had real science and real consumer insight to back that up, she said

Dose titration protocols may be appropriate for certain research designs

Victoza was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. But we dont have to look at previous generations of GLP-1s so see the risk that unknown side effects have

Quality sleep and stress management also support immune function during detox